Universitat de Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (44)

2024

  1. Emotional intelligence and neurocognition profiles in first-episode psychosis: A two-year follow-up study

    European Neuropsychopharmacology, Vol. 85, pp. 66-77

  2. Exploring the reactivity of bicyclic α-iminophosphonates to access new imidazoline I2 receptor ligands

    Bioorganic Chemistry, Vol. 142

  3. NRN1 epistasis with BDNF and CACNA1C: mediation effects on symptom severity through neuroanatomical changes in schizophrenia

    Brain Structure and Function, Vol. 229, Núm. 5, pp. 1299-1315

  4. Negative symptoms and sex differences in first episode schizophrenia: What's their role in the functional outcome? A longitudinal study

    Spanish Journal of Psychiatry and Mental Health

  5. The CB1 receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls

    EMBO Molecular Medicine, Vol. 16, Núm. 4, pp. 755-783

2023

  1. Obstetric complications and genetic risk for schizophrenia: Differential role of antenatal and perinatal events in first episode psychosis

    Acta Psychiatrica Scandinavica

  2. Peripheral CB1 receptor blockade acts as a memory enhancer through a noradrenergic mechanism

    Neuropsychopharmacology, Vol. 48, Núm. 2, pp. 341-350

  3. Preclinical Evaluation of an Imidazole-Linked Heterocycle for Alzheimer’s Disease

    Pharmaceutics, Vol. 15, Núm. 10

  4. Selective inhibition of cannabinoid CB1 receptor-evoked signalling by the interacting protein GAP43

    Neuropharmacology, Vol. 240

2022

  1. Four-month incidence of suicidal thoughts and behaviors among healthcare workers after the first wave of the Spain COVID-19 pandemic

    Journal of Psychiatric Research, Vol. 149, pp. 10-17

  2. High S100B Levels Predict Antidepressant Response in Patients With Major Depression Even When Considering Inflammatory and Metabolic Markers

    International Journal of Neuropsychopharmacology, Vol. 25, Núm. 6, pp. 468-478

  3. NRN1 Gene as a Potential Marker of Early-Onset Schizophrenia: Evidence from Genetic and Neuroimaging Approaches

    International Journal of Molecular Sciences, Vol. 23, Núm. 13

2021

  1. Adrenergic Modulation With Photochromic Ligands

    Angewandte Chemie - International Edition, Vol. 60, Núm. 7, pp. 3625-3631

  2. Benzofuranyl-2-imidazoles as imidazoline I2 receptor ligands for Alzheimer's disease

    European Journal of Medicinal Chemistry, Vol. 222

  3. Decreased striatal adenosine A2A-dopamine D2 receptor heteromerization in schizophrenia

    Neuropsychopharmacology, Vol. 46, Núm. 3, pp. 665-672

  4. Identification of bip as a cb1 receptor-interacting protein that fine-tunes cannabinoid signaling in the mouse brain

    Journal of Neuroscience, Vol. 41, Núm. 38, pp. 7924-7941

  5. Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis

    Schizophrenia Research, Vol. 236, pp. 19-28

  6. The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis

    Psychopharmacology, Vol. 238, Núm. 3, pp. 665-676

2020

  1. Bicyclic α-Iminophosphonates as High Affinity Imidazoline I2 Receptor Ligands for Alzheimer's Disease

    Journal of Medicinal Chemistry, Vol. 63, Núm. 7, pp. 3610-3633

  2. Birth weight and antipsychotic induced weight gain: A prenatal programming approach in the PEPs study

    Schizophrenia Research, Vol. 218, pp. 292-294